Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yawei Zhang

Showing results (521-530 of 773) with videos related to

Pageof 78
Sort By:
Annals of Surgical Oncology|December 22, 2019
Imaging Features Suggestive of Multiple Primary Lung AdenocarcinomasYiliang Zhang, Guodong Li, Yuan Li, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2020
In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from ChinaXiaojuan Wang, Chunjiang Zhao, Qi Wang, et al.
Journal of Thoracic Disease|July 19, 2021
Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinomaZhigang Wu, Qiang Zheng, Haiquan Chen, et al.
Journal of Affective Disorders|June 1, 2023
Physical activity domains and patterns with risk of depressive symptoms: A cross-sectional study in ChinaRanran Qie, Huang Huang, Peiyuan Sun, et al.
Cancer Biology & Medicine|February 19, 2026
Single-cell and spatial transcriptome analyses reveal tumor immunometabolism in lymph node metastasis of lung cancerYang Zhang, Wangyang Zhu, Chaoqiang Deng, et al.
The Journal of Antimicrobial Chemotherapy|April 27, 2020
Erratum to: In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from ChinaXiaojuan Wang, Chunjiang Zhao, Qi Wang, et al.
Expert Review of Vaccines|August 15, 2017
Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trialYongliang Feng, Xiaohong Shi, Jing Shi, et al.
Journal of Cancer|November 21, 2017
A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinomaWeiwei Yu, Li Chu, Kuaile Zhao, et al.
Hematological Oncology|July 27, 2010
Variation in innate immunity genes and risk of multiple myelomaMark P Purdue, Qing Lan, Idan Menashe, et al.
American Journal of Epidemiology|December 6, 2008
Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut womenRong Wang, Yawei Zhang, Qing Lan, et al.
Pageof 78

Showing results (521-530 of 773) with videos related to

Sort By:
Pageof 78
Annals of Surgical Oncology|December 22, 2019
Imaging Features Suggestive of Multiple Primary Lung AdenocarcinomasYiliang Zhang, Guodong Li, Yuan Li, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2020
In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from ChinaXiaojuan Wang, Chunjiang Zhao, Qi Wang, et al.
Journal of Thoracic Disease|July 19, 2021
Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinomaZhigang Wu, Qiang Zheng, Haiquan Chen, et al.
Journal of Affective Disorders|June 1, 2023
Physical activity domains and patterns with risk of depressive symptoms: A cross-sectional study in ChinaRanran Qie, Huang Huang, Peiyuan Sun, et al.
Cancer Biology & Medicine|February 19, 2026
Single-cell and spatial transcriptome analyses reveal tumor immunometabolism in lymph node metastasis of lung cancerYang Zhang, Wangyang Zhu, Chaoqiang Deng, et al.
The Journal of Antimicrobial Chemotherapy|April 27, 2020
Erratum to: In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from ChinaXiaojuan Wang, Chunjiang Zhao, Qi Wang, et al.
Expert Review of Vaccines|August 15, 2017
Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trialYongliang Feng, Xiaohong Shi, Jing Shi, et al.
Journal of Cancer|November 21, 2017
A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinomaWeiwei Yu, Li Chu, Kuaile Zhao, et al.
Hematological Oncology|July 27, 2010
Variation in innate immunity genes and risk of multiple myelomaMark P Purdue, Qing Lan, Idan Menashe, et al.
American Journal of Epidemiology|December 6, 2008
Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut womenRong Wang, Yawei Zhang, Qing Lan, et al.
Pageof 78